Kursprognose für Tempest Therapeutics Inc (TPST)TPSTTempest Therapeutics Inc

Alphio's TPST stock price prediction model matches the current Tempest Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.38 (+0.01%). The 1-week path is $0.38 (+0.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Tempest Therapeutics Inc (TPST) is not a good buy right now. The current price is $0.3801, which is significantly lower than the 52-week high of $10.33, indicating a drastic decline of 96.12% over the past year. Additionally, the RSI is at a very low 10.575, suggesting extreme oversold conditions, but this could reflect deeper underlying issues rather than a buying opportunity. The company has reported a net income loss of $27,696,000 for Q1 2026, which raises concerns about its financial stability. The recent financing news has not positively impacted the stock, as it fell 4.60% after announcing a private placement to raise $2.5 million, reflecting market skepticism about its future prospects. The main risk is the company's ongoing losses and reliance on external funding, which could further dilute shareholder value.

Tempest Therapeutics Inc (TPST) last closed at $0.3801, gaining +1.31%. These facts feed the 1-day and 1-week TPST price prediction above.